Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognosis in malignant melanoma

W K Stadelmann1, D S Reintgen

  • 1Division of Plastic and Reconstructive Surgery, University of Louisville, Kentucky, USA.

Hematology/Oncology Clinics of North America
|October 6, 1998
PubMed
Summary

A uniform melanoma staging system is crucial for comparing treatment outcomes. This review examines the 1992 American Joint Committee on Cancer pTNM staging system for melanoma classification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A molecular technique useful in the detection of occult metastases in patients with melanoma : rt-PCR analysis of sentinel lymph nodes and peripheral blood.

Methods in molecular medicine·2012
Same author

Controversial topics in breast lymphatic mapping.

Seminars in oncology·2004
Same author

The use of selective lymphadenectomy in malignant blue naevus of the scalp.

British journal of plastic surgery·2003
Same author

Importance of missed axillary micrometastases in breast cancer patients.

The breast journal·2002
Same author

Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis.

Journal of the American College of Surgeons·2002
Same author

Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection.

Annals of surgical oncology·2002

Area of Science:

  • Oncology
  • Dermatology

Background:

  • Effective melanoma treatment relies on a standardized classification and staging system.
  • Comparisons between treatment centers and databases require a widely adopted system.

Purpose of the Study:

  • To review the 1992 American Joint Committee on Cancer pTNM staging system for melanoma.

Main Methods:

  • Review of the 1992 American Joint Committee on Cancer pTNM staging system.

Main Results:

  • Stage I/II: Localized melanoma without nodal involvement, based on tumor thickness.
  • Stage III: Regional lymph node involvement or in-transit metastasis.
  • Stage IV: Systemic metastatic disease.

Conclusions:

  • The 1992 pTNM staging system categorizes melanoma based on tumor characteristics and spread.
  • Understanding this system is essential for consistent melanoma diagnosis and treatment evaluation.

Related Experiment Videos